ABBOTT's NDA FOR CARTROL (CARTEOLOL) GIVES FIRM TWO CARDIOVASCULAR APPLICATIONS PENDING AT FDA AND AT LEAST SEVEN MDAs OVERALL; BAXTER EARNINGS, SALES OFF